+794.9%
MRNA vs HST
+53.2%
+741.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HST | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.1% | -3.4% | -3.4% |
| 7D | -12.1% | +3.6% | -15.7% | -15.6% |
| 30D | -1.3% | +11.2% | -12.5% | -11.5% |
| 3M | +250.9% | +13.1% | +237.8% | +211.3% |
| 6M | +343.0% | +23.9% | +319.1% | +248.9% |
| YTD | +657.4% | +52.3% | +605.2% | +369.3% |
| 1Y | +794.9% | +56.7% | +738.2% | +443.3% |
| All | +794.9% | +53.2% | +741.7% | +443.3% |
Cumulative growth
Daily Returns
Daily percentage return beside HST.
Daily Out/Under-Performance
Portfolio return minus HST return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HST return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HST wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling